Arijitt Borthakur

Arijitt Borthakur

Auto-generated profile, based on publicly available information

Arijitt Borthakur

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2009 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
EME.A. Mellon
E.A. Mellon
DPD.T. Pilkinton
D.T. Pilkinton
CCC.M. Clark
C.M. Clark
MEM.A. Elliott
M.A. Elliott
WWW.R. Witschey
W.R. Witschey
RRR. Reddy
R. Reddy
BACKGROUND AND PURPOSE: There is significant interest in the development of novel noninvasive techniques for the diagnosis of Alzheimer disease (AD) and tracking its progression. Because MR imaging has detected alterations in sodium levels that correlate with cell death in stroke, we hypothesized that there would be alterations of sodium levels in the brains of patients with AD, related to AD cell death. MATERIALS AND METHODS: A total of 10 volunteers (5 with mild AD and 5 healthy control subjects) were scanned with a 20-minute sodium (23Na) MR imaging protocol on a 3T clinical scanner. RESULTS: After normalizing the signal intensity from the medial temporal lobes corresponding to the hippocampus with the ventricular signal intensity, we were able to detect a 7.5% signal intensity increase in the brains of patients with AD (AD group, 68.25% ± 3.4% vs control group, 60.75% ± 2.9%; P < .01). This signal intensity enhancement inversely correlated with hippocampal volume (AD group, 3.22 ± 0.50 cm3 vs control group, 3.91 ± 0.45 cm3; r2 = 0.50). CONCLUSIONS: This finding suggests that sodium imaging may be a clinically useful tool to detect the neuropathologic changes associated with AD.

5 September 2008 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
WWWalter R.T. Witschey
Walter R.T. Witschey
ABArijitt Borthakur
Arijitt Borthakur
MEMark A. Elliott
Mark A. Elliott
MFMatthew Fenty
Matthew Fenty
MSMatthew A. Sochor
Matthew A. Sochor
RRRavinder Reddy
Ravinder Reddy
Purpose: To develop a T1ρ‐prepared, balanced gradient echo (b‐GRE) pulse sequence for rapid three‐dimensional (3D) T1ρ relaxation mapping within the time constraints of a clinical exam (<10 minutes), examine the effect of acquisition on the measured T1ρ relaxation time and optimize 3D T1ρ pulse sequences for the knee joint and spine.Materials and Methods: A pulse sequence consisting of inversion recovery–prepared, fat saturation, T1ρ‐preparation, and b‐GRE image acquisition was used to obtain 3D volume coverage of the patellofemoral and tibiofemoral cartilage and lower lumbar spine. Multiple T1ρ‐weighted images at various contrast times (spin‐lock pulse duration [TSL]) were used to construct a T1ρ relaxation map in both phantoms and in the knee joint and spine in vivo. The transient signal decay during b‐GRE image acquisition was corrected using a k‐space filter. The T1ρ‐prepared b‐GRE sequence was compared to a standard T1ρ‐prepared spin echo (SE) sequence and pulse sequence parameters were optimized numerically using the Bloch equations.Results: The b‐GRE transient signal decay was found to depend on the initial T1ρ‐preparation and the corresponding T1ρ map was altered by variations in the point spread function with TSL. In a two compartment phantom, the steady state response was found to elevate T1ρ from 91.4 ± 6.5 to 293.8 ± 31 and 66.9 ± 3.5 to 661 ± 207 with no change in the goodness‐of‐fit parameter R2. Phase encoding along the longest cartilage dimension and a transient signal decay k‐space filter retained T1ρ contrast. Measurement of T1ρ using the T1ρ‐prepared b‐GRE sequence matches standard T1ρ‐prepared SE in the medial patellar and lateral patellar cartilage compartments. T1ρ‐preparedb‐GRE T1ρ was found to have low interscan variability between four separate scans. Mean patellar cartilage T1ρ was elevated compared to femoral and tibial cartilage T1ρ.Conclusion: The T1ρ‐prepared b‐GRE acquisition rapidly and reliably accelerates T1ρ quantification of tissues offset partially by a TSL‐dependent point spread function. J. Magn. Reson. Imaging 2008;28:744–754.

20 November 2020 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SWSusan P. Weinstein
Susan P. Weinstein
KKKatrina Korhonen
Katrina Korhonen
CCClaire Cirelli
Claire Cirelli
MSMitchell D. Schnall
Mitchell D. Schnall
EMElizabeth S. McDonald
Elizabeth S. McDonald
ECEmily F Conant
Emily F Conant
PURPOSE: Although mammography is the standard of care for breast cancer screening, dense breast tissue decreases mammographic sensitivity. We report the prevalent cancer detection rate (CDR) from the first clinical implementation of abbreviated breast magnetic resonance imaging (AB-MR) as a supplemental screening test in women with dense breasts. METHODS: The study was approved by the institutional review board and is Health Insurance Portability and Accountability Act complaint. This retrospective review includes women who were imaged between January 1, 2016 and February 28, 2019. On a 1.5 Tesla magnet, the imaging protocol consisted of three sequences: Short-TI Inversion Recovery (STIR), precontrast, and postcontrast. A subtraction sequence and a maximum intensity projection were generated. We report the patient-level CDR and the positive predictive value of AB-MR examinations after negative/benign digital breast tomosynthesis (DBT). RESULTS: Out of 511 prevalent rounds of AB-MR examinations, 36 women were excluded. The remaining 475 asymptomatic women with dense breasts had negative/benign DBT examinations before the AB-MR. There were 420 of 475 (88.4%) benign/negative examinations, 13 of 475 (2.7%) follow-up recommendations, and 42 biopsy recommendations. Thirty-nine biopsies were completed, resulting in 12/39 (30.8%) malignancies in 12 women: seven invasive carcinomas and five ductal carcinoma in situ. One additional patient was diagnosed with invasive ductal carcinoma at the time of 6-month follow-up. The CDR was 27.4 per 1,000 (13 of 475; 95% CI, 16.1 to 46.3). The size of invasive carcinomas ranged from 0.6-1.0 cm (mean, 0.5 cm). Of the seven women who underwent surgical evaluation of the axilla, zero of seven patients had positive nodes. There were no interval cancers at 1-year follow-up. CONCLUSION: Preliminary results from clinical implementation of screening AB-MR resulted in a CDR of 27.4/1,000 at the patient level after DBT in women with dense breasts. Additional evaluation is warranted.

1 January 2024 in Radiology
Verified
Journal Article
Closed access
ACAllison Chae
Allison Chae
MYMichael S. Yao
Michael S. Yao
Hersh SagreiyaHersh Sagreiya
Hersh Sagreiya
AGAri D. Goldberg
Ari D. Goldberg
NCNeil Chatterjee
Neil Chatterjee
JGJames C. Gee
James C. Gee
Despite recent advancements in machine learning (ML) applications in health care, there have been few benefits and improvements to clinical medicine in the hospital setting. To facilitate clinical adaptation of methods in ML, this review proposes a standardized framework for the step-by-step implementation of artificial intelligence into the clinical practice of radiology that focuses on three key components: problem identification, stakeholder alignment, and pipeline integration. A review of the recent literature and empirical evidence in radiologic imaging applications justifies this approach and offers a discussion on structuring implementation efforts to help other hospital practices leverage ML to improve patient care. Clinical trial registration no. 04242667 © RSNA, 2024 Supplemental material is available for this article.

18 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
RTRichard H. Tran
Richard H. Tran
PRPavan S Raghupathy
Pavan S Raghupathy
MHMohamad Hazim
Mohamad Hazim
ETElizabeth Thompson
Elizabeth Thompson
SSSophia Swago
Sophia Swago
Hersh SagreiyaHersh Sagreiya
Hersh Sagreiya
Aims: The distribution of abdominal adipose depots and their mechanistic links to type 2 diabetes remain incompletely understood. This study elucidated the relationship between type 2 diabetes presence and quantitative abdominal imaging traits, including hepatic steatosis, liver and spleen size, and adipose distribution, using unenhanced computed tomography (CT) scans from a large-scale, racially diverse, disease-focused medical biobank. Materials and Methods: Deep learning algorithms were applied to abdominal CT scans to automatically quantify image-derived phenotypes, including spleen-hepatic attenuation difference (SHAD) for hepatic steatosis, liver and spleen volumes (LV and SV, respectively), visceral and subcutaneous adipose tissue (VAT and SAT, respectively), and visceral-to-subcutaneous fat ratio (VSR). Results: Diabetic individuals demonstrated a greater degree of hepatic steatosis and central adiposity than those without diabetes. Liver attenuation was lower (47.6 vs. 52.4 Hounsfield units (HU); lower values indicate greater steatosis), SHAD was higher (−5.41 vs. −8.41 HU; more positive values indicate greater steatosis), and steatosis prevalence increased (38.4% vs. 21.4%) (all p<2.2×10⁻¹⁶). VSR was also elevated (0.64 vs. 0.54, p=5.86×10⁻¹³). These trends remained significant after stratification by sex. Multivariate analyses revealed independent associations of diabetes with SHAD (OR 1.04), LV (OR 1.59), SV (OR 3.95), VAT (OR 1.23), SAT (OR 1.05), and VSR (OR 2.27), after adjusting for age, sex, race, and BMI. Conclusions: Hepatic steatosis, hepatomegaly, and visceral adiposity on CT imaging are predictive of type 2 diabetes presence. Notably, VSR showed a stronger association with diabetes than BMI, underscoring how body-fat distribution, rather than overall adiposity, more accurately reflects metabolic disease risk.